000			02688nam a22002537a 4500
008			210917b2021 |||||||| |||| 00| 0 eng d
020			_a9781108971638
020			_a9781108838573
020			_a9781108975292
060			_aWM 402.
100	1		_aStahl, Stephen M
245	1	0	_aStahl's essential psychopharmacology : _bneuroscientific basis and practical applications / _h[E-Book]
250			_a5th ed.
260			_aCambridge : _bCambridge University Press, _c2021
300			_axv, 608p.
490			_aCambridge medicine
505			_a1. Chemical Neurotransmission 2. Transporters, Receptors and Enzymes as Targets of Psychopharmacological Drug Action 3. Ion Channels as Targets of Psychopharmacological Drug Action 4. Psychosis, Schizophrenia and the Neurotransmitter Networks Dopamine, Serotonin and Glutamate 5. Targeting Dopamine and Serotonin Receptors for Psychosis, Mood and Beyond: So-Called 'Antipsychotics' 6. Mood Disorders and the Neurotransmitter Networks Norepinephrine and Gamma Amino Butyric Acid (Gaba) 7. Treatments for Mood Disorders: So-Called 'Antidepressants' and 'Mood Stabilizers' 8. Anxiety, Trauma and Treatment 9. Chronic Pain and its Treatment 10. Disorders of Sleep and Wakefulness and their Treatment: Neurotransmitter Networks for Histamine and Orexin 11. Attention Deficit Hyperactivity Disorder and its Treatment 12. Dementia: Causes, Symptomatic Treatments and the Neurotransmitter Network Acetylcholine 13. Impulsivity, Compulsivity and Addiction Suggested Reading and Selected References Index.
520			_aLong established as the preeminent source in its field, the eagerly anticipated fifth edition of Dr Stahl's essential textbook of psychopharmacology is here! With its use of icons and figures that form Dr Stahl's unique 'visual language', the book is the single most readable source of information on disease and drug mechanisms for all students and mental health professionals seeking to understand and utilize current therapeutics, and to anticipate the future for novel medications. Every aspect of the book has been updated, with the clarity of explanation that only Dr Stahl can bring. The new edition includes over 500 new or refreshed figures, an intuitive color scheme, fourteen new uses for older drugs and eighteen brand new drugs, coverage of Parkinson's Disease Psychosis, behavioural symptoms of dementia, and mixed features in major depressive episodes, and expanded information on the medical uses of cannabis and hallucinogen assisted psychotherapy.
650			_aPsychopharmacology
650			_aNeurobiology _97115
650			_aDrug therapy
650			_aPsychotropic drugs _97615
942			_n0
999			_c42714 _d42714